Whole‐transcriptome sequencing uncovers core regulatory modules and gene signatures of human fetal growth restriction

Abstract

BackgroundFetal growth restriction (FGR) contributes the primary cause of perinatal mortality and morbidity with impacts on the long‐term health. To determine the core gene expression network and gene signatures, which in combination with ultrasound confirmation will more effectively differentiate constitutionally normal small for gestational age and pathological FGR groups, we performed RNA sequencing for protein‐coding genes, lncRNAs, and small RNAs in a case–control study of umbilical cord blood. ResultsFive pairs of FGR case and control umbilical cord blood samples were used for RNA sequencing and weighted gene co‐expression network analysis (WGCNA). Results showed that 339 mRNAs, 295 lncRNAs, and 13 miRNAs were significantly differentially expressed between FGR cases and controls. Bioinformatics analysis indicated that these differentially expressed molecules were mainly involved in metabolism, neural, cardiac, and immune systems, and identified 18 WGCNA modules for FGR. Further quantitative verification was performed using umbilical cord blood and maternal peripheral blood from 12 pairs of FGR cases and controls. The logistic regression and receiver operating characteristic curve indicated that RP11_552M6.1, LINC01291, and Asgr1 in umbilical cord blood, while Sfrp2, miR‐432‐5p, and miR‐1306‐3p in maternal peripheral blood had potential significance for FGR. ConclusionsWe comprehensively profiled the whole‐transcriptome landscape of human umbilical cord blood with FGR, constructed the core WGCNA modules, and delineated the critical gene signatures of FGR. These findings provide key insight into intrauterine perturbations and candidate signatures for FGR.

Overexpression of miR-1306-5p, miR-3195, and miR-3914 Inhibits Ameloblast Differentiation through Suppression of Genes Associated with Human Amelogenesis Imperfecta

“…We found that overexpression of miR-1306-5p, miR-3195, and miR-3914 inhibits ameloblast differentiation. miR-1306 is upregulated in the plasma of mothers who are delivering babies with fatal growth restriction [ 42 ]. miR-3195 is expressed in several cancers and can induce apoptosis, acting as a tumor suppressor [ 43 , 44 , 45 ], whereas miR-3914′s expression profile has not been reported.…”

Trans‐omic profiling between clinical phenoms and lipidomes among patients with different subtypes of lung cancer

“…The trans-omic modules can reflect regulatory mechanisms by which cell survival and differentiation, organ function and metabolism, and systemic response and dysfunction are controlled. 17,32,33 Those lipid metabolites and related limiting enzymes can be regulated by up/down-expression of the corresponding genes and mitochondrial DNA methylation and fusion/ fission. 34,35 There were also limitations in this study.…”

“…For example, lysoPS (16:0 and 22:6) were involved in the appearance of sputum, dysphagia, and hemoptysis in patients with ADC. The trans‐omic modules can reflect regulatory mechanisms by which cell survival and differentiation, organ function and metabolism, and systemic response and dysfunction are controlled 17,32,33 . Those lipid metabolites and related limiting enzymes can be regulated by up/down‐expression of the corresponding genes and mitochondrial DNA methylation and fusion/fission 34,35 …”

The overlap between Alzheimer's disease and epilepsy uncovered by transcriptome sequencing

“…While, cellular metabolic process and metabolic process were the most enriched up‐regulated GO terms in epileptic mice (Figure 1D). In order to determine the signal transduction pathways involved in DEGs, 6 we conducted KEGG analysis. Figure 1E illustrated that phagosome (corrected P = 0.0014) and antigen processing and presentation (corrected P = 0.0014) pathways were significant up‐regulated in APP/PS1 mice.…”